Pathway to diagnosing gluten intolerance

Ben Falkenmire

writer

Ben Falkenmire

Writer

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Ben Falkenmire

 
A process of exclusion and patience

When a patient presents with stomach problems like diarrhoea and bloating, the lack of guidelines available can make the task of diagnosing gluten intolerance a challenging and time-consuming one for GPs.

Gastroenterologist and Head of Colorectal Medicine and Genetics at Royal Melbourne Hospital, Professor Finlay Macrae, advises GPs to test for coeliac disease first, because of long term risks of cancer and bone loss.

Professor Finlay Macrae is lecturing on gluten intolerance in the upcoming free Healthed webcast on [25th October ]. Register here.

In the first consult, he will also ask the patient to go dairy free for three weeks and monitor for improvements.

“The serology for coeliac disease is pretty reliable for diagnosis, and if it’s positive, a confirmation with a biopsy and gastroscopy,” Professor Macrae says.

“I don’t think any of the breath tests for lactose intolerance are reliable enough or need to be done. The proof is in the pudding.”

Should both return negative results, he says inflammatory bowel disease can be excluded with a high level of certainty with normal ESR, CRP and faecal calprotectin levels.

“Other diagnoses to consider are small bacterial overgrowth, bile salt spill over, and microscopic colitis,” Professor Macrae says.

“If all of these are negative and the patient is under 50 years old, then irritable bowel syndrome (IBS) is the likely diagnosis.”

According to Professor Macrae, some IBS patients benefit from a gluten free diet. For them, he recommends the low FODMAP diet, providing the patient with an information sheet of high FODMAP foods to avoid, and advising them to download and use the Monash FODMAP app.

“I also suggest a dietician. Attention to calcium and vitamin D levels is important, and a patient can run into trouble if they exclude meat and become iron deficient,” he says.

If the patient is showing signs of ongoing distress, Professor Macrae says targeting the gut-brain axis with a pharmacological intervention or clinical psychology can be beneficial.

“Amitriptyline at very low doses is still the main treatment we use to modulate the gut-brain axis and improve symptomatology,” he says.

“A patient might be more amenable and more comfortable with a clinical psychological approach to manage what we’d be now addressing as IBS, having ruled out the other possibilities.”

The jury is still out on the causes non-coeliac gluten sensitivity and how to test for it. Professor Macrae is not a fan of clinical microbiome testing, or the expensive tests patients can undertake at boutique labs specialising in the microbiome.

“There are various hypotheses about agents inciting gluten intolerance, such as the amylase trypsin inhibitor which comes from the pancreas, but the cause and the picture of what’s going on are still uncertain,” he says.

“There’s no good evidence faecal microbial transplantation or probiotics are of any use in IBS. Other microbial testing done by less than mainstream diagnostic labs is difficult to interpret.”

Professor Finlay Macrae is lecturing on gluten intolerance in the upcoming free Healthed webcast on [25th October ]. Register here.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Ben Falkenmire

writer

Ben Falkenmire

Writer

Test your knowledge

Recent articles

Latest GP poll

Has a clinic you work at ever received an unfair negative online review?

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease